Filtered By:
Condition: Depression
Education: Study
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 5383 results found since Jan 2013.
Depressive Symptoms and Anger Expression Among Survivors After Stroke
CONCLUSIONS: Early detection and management of depression and anger will facilitate patient's compliance to the rehabilitation program in order to achieve optimal therapeutic results and ensure a better quality of life.PMID:37581799 | DOI:10.1007/978-3-031-31986-0_24
Source: Advances in Experimental Medicine and Biology - August 15, 2023 Category: Research Authors: Anastasia Papadopoulou Panagiotis Papadopoulos Eirini Grammatopoulou Anna Kavga Alexandra Koreli Alexandra Mantoudi Angeliki Stamou Georgia Gerogianni Afroditi Zartaloudi Source Type: research
Chronic comorbid conditions and asthma exacerbation occurrence in a general population sample
In conclusion, several chronic comorbid conditions were associated with asthma exacerbation occurrence, which confirms but also complements previous studies. Our observations contribute to understanding exacerbation risk estimation and, ultimately, personalized asthma management.PMID:37567896 | DOI:10.1038/s41533-023-00350-x
Source: Primary Care - August 11, 2023 Category: Primary Care Authors: Emma Baljet Hilde Luijks Lisette van den Bemt Tjard R Schermer Source Type: research
Neuroprotective Effects of Phenolic Antioxidant Tert-butylhydroquinone (tBHQ) in Brain Diseases
This article reviews the effects of tBHQ on neuroinflammation and oxidative stress in recent years and looks into how tBHQ inhibits neuroinflammation and oxidative stress through human, animal, and cell experiments to play a neuroprotective role in Alzheimer’s disease (AD), stroke, depression, and Parkinson’s disease (PD). It is anticipated that this article will be useful as a reference for upcoming research and the creation of drugs to treat brain diseases.
Source: Molecular Neurobiology - August 10, 2023 Category: Neurology Source Type: research
Poststroke Depression: An Update
J Neuropsychiatry Clin Neurosci. 2023 Aug 10:0. doi: 10.1176/appi.neuropsych.21090231. Online ahead of print.ABSTRACTThe presence of neuropsychiatric disorders after stroke has been recognized for more than 100 years, but controlled systematic studies did not begin until the 1970s. The most clinically important advances, however, have been in the treatment and prevention of poststroke depression (PSD). Recent meta-analyses of randomized controlled trials (RCTs) for the treatment of PSD have demonstrated the efficacy of antidepressants. Similarly, RCTs for the prevention of PSD have shown that antidepressants significantly ...
Source: Journal of Neuropsychiatry and Clinical Neurosciences - August 10, 2023 Category: Psychiatry Authors: Robert G Robinson Ricardo E Jorge Sergio E Starkstein Source Type: research
